GH1 and neoplasm: The clinical status of acromegaly can be assessed using SAGIT, a comprehensive clinician-reported outcome instrument that analyzes five key features of the disease: signs and symptoms (S), associated comorbidities (A), GH levels (G), IGF-1 levels (I), and the tumor profile (T) [5,14].